IL311382A - Drug delivery system for locally delivering therapeutic agents and uses thereof - Google Patents
Drug delivery system for locally delivering therapeutic agents and uses thereofInfo
- Publication number
- IL311382A IL311382A IL311382A IL31138224A IL311382A IL 311382 A IL311382 A IL 311382A IL 311382 A IL311382 A IL 311382A IL 31138224 A IL31138224 A IL 31138224A IL 311382 A IL311382 A IL 311382A
- Authority
- IL
- Israel
- Prior art keywords
- drug administration
- local delivery
- administration system
- therapeutic substances
- therapeutic
- Prior art date
Links
- 238000001647 drug administration Methods 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021118666 | 2021-09-16 | ||
| PCT/CN2022/118658 WO2023040879A1 (en) | 2021-09-16 | 2022-09-14 | Drug delivery system for locally delivering therapeutic agents and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL311382A true IL311382A (en) | 2024-05-01 |
Family
ID=85602430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL311382A IL311382A (en) | 2021-09-16 | 2022-09-14 | Drug delivery system for locally delivering therapeutic agents and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240398963A1 (https=) |
| EP (1) | EP4402152A1 (https=) |
| JP (1) | JP2024533034A (https=) |
| KR (1) | KR20240056728A (https=) |
| CN (1) | CN118019750A (https=) |
| AU (1) | AU2022348759A1 (https=) |
| CA (1) | CA3227319A1 (https=) |
| IL (1) | IL311382A (https=) |
| WO (1) | WO2023040879A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026002095A1 (en) * | 2024-06-26 | 2026-01-02 | Coval Biopharma (Shanghai) Co., Ltd. | Drug delivery system for locally controlled release of therapeutic agents and uses thereof |
| CN119735627B (zh) * | 2024-12-25 | 2025-10-21 | 西北农林科技大学 | 甾体并3，4二氢吡咯吡嗪酮衍生物及其合成方法与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009096749A (ja) * | 2007-10-16 | 2009-05-07 | Konica Minolta Holdings Inc | コレステロール誘導体、リポソーム及びｘ線用造影剤 |
| SG11201609490QA (en) * | 2014-05-15 | 2016-12-29 | Agency Science Tech & Res | Polymer-flavonoid conjugate and uses thereof |
-
2022
- 2022-09-14 CN CN202280062538.8A patent/CN118019750A/zh active Pending
- 2022-09-14 CA CA3227319A patent/CA3227319A1/en active Pending
- 2022-09-14 AU AU2022348759A patent/AU2022348759A1/en active Pending
- 2022-09-14 WO PCT/CN2022/118658 patent/WO2023040879A1/en not_active Ceased
- 2022-09-14 IL IL311382A patent/IL311382A/en unknown
- 2022-09-14 KR KR1020247009326A patent/KR20240056728A/ko active Pending
- 2022-09-14 EP EP22869248.9A patent/EP4402152A1/en active Pending
- 2022-09-14 US US18/692,340 patent/US20240398963A1/en active Pending
- 2022-09-14 JP JP2024506186A patent/JP2024533034A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024533034A (ja) | 2024-09-12 |
| KR20240056728A (ko) | 2024-04-30 |
| WO2023040879A1 (en) | 2023-03-23 |
| CN118019750A (zh) | 2024-05-10 |
| CA3227319A1 (en) | 2023-03-23 |
| EP4402152A1 (en) | 2024-07-24 |
| US20240398963A1 (en) | 2024-12-05 |
| AU2022348759A1 (en) | 2024-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286539A (en) | Pharmaceutical composition, comprising human hyaluronidase ph20 variant and drug, for subcutaneous injection | |
| BR112018013245A2 (pt) | método e aparelho para administração óxido nítrico com drogas suplementares | |
| IL307997A (en) | Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases | |
| IL284733A (en) | Pharmaceutical delivery compositions and uses thereof | |
| EP4045024A4 (en) | TRANSDERMAL ADMINISTRATION OF CANNABIDIOL | |
| IL311382A (en) | Drug delivery system for locally delivering therapeutic agents and uses thereof | |
| PH12019500061A1 (en) | Oral gastroretentive formulations and uses thereof | |
| KR20240101682A9 (ko) | 이중특이 항체-캄프토테신 약물 접합체 및 이의 약학적 용도 | |
| CY1119805T1 (el) | Συστημα χορηγησης φαρμακων για τη χορηγηση πτωχως υδατοδιαλυτων φαρμακευτικως ενεργων ουσιων | |
| EP3354306A4 (en) | DRUG ADMINISTRATIVE AND DRUG ADMINISTRATION UNIT | |
| EP3700617A4 (en) | SYSTEMS AND METHODS FOR ADMINISTERING NEUROR-REGENERATIVE THERAPY | |
| EP3962661A4 (en) | DEVICES AND METHODS FOR NASAL DRUG OR AGENTS DELIVERY | |
| JOP20240078A1 (ar) | تركيبات إردافيتينيب وأنظمة الإعطاء داخل المثانة | |
| EP3485887A4 (en) | INJECTABLE PHARMACEUTICAL COMPOSITION OF TECOVIRIMAT AND PRODUCTION METHOD THEREFOR | |
| EP4464300C0 (en) | CLOSED TYPE LIQUID DRUG TRANSFER DEVICE AND SYSTEM WITH DUAL-CHAMBER INTERNAL CIRCULATION | |
| IL285073A (en) | Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same | |
| BR102019016950A2 (pt) | forma de dosagem intrauretral de medicamento; e dispositivo | |
| EP4146302A4 (en) | DRUG DELIVERY SYSTEM FOR DELIVERY OF ANTIVIRAL AGENTS AND CONTRACEPTIVES | |
| IL287912A (en) | Pharmaceutical composition of a weak acid drug and methods of administration | |
| EP3765122A4 (en) | MEDICAL INSTRUMENT AND MEDICAL PROCEDURE FOR LOCALIZED ACTIVE SUBSTANCE RELEASE | |
| BR112017022984A2 (pt) | dispositivo para facilitar o posicionamento de um cateter para administrar um medicamento em um paciente que esteja respirando espontaneamente | |
| EP4395726A4 (en) | CLOSED SYSTEM FOR THE PREPARATION AND ADMINISTRATION OF STERILE MEDICATION | |
| EP4404996A4 (en) | PUMP MECHANISM FOR DRUG DELIVERY AND DRUG DELIVERY SYSTEM | |
| IL313742A (en) | A system for administering drugs and methods for using it | |
| MX2020006886A (es) | Sistema para suministro de medicamento. |